lycopene/悪性腫瘍

CROSS-REFERENCE TO RELATED APPLICATIONS This United States utility patent application is the .sctn.371 national phase of PCT international patent application no PCT/SG2010/000147, having an international filing date of Apr. 13, 2010, which claims benefit of priority to Singapore Patent Applications

FIELD OF THE INVENTION The present invention is concerned with a multi-stage process for the manufacture of an oxidative metabolite of the carotenoid lycopene as well a novel intermediates produced in the manufacturing process. BACKGROUND OF THE INVENTION As is known, carotenoids, inter alia,

FIELD OF THE INVENTION The present invention relates to an efficient process for the preparation of lycopene containing oleoresin and lycopene crystals for human consumption. More particularly, the present invention relates to a process for the preparation of tomato oleoresin and lycopene crystals

1. INTRODUCTION The present application relates to methods of treating or preventing proliferative disease, particularly cancer, by administering to a subject a composition comprising lycopene and alpha-tocopherol. 2. BACKGROUND OF THE INVENTION Lycopene, a natural red carotenoid found in nature in

BACKGROUND OF THE INVENTION 1. Field of the Invention The invention relates to a method and composition for the treatment and alleviation of symptoms of benign prostatic hypertrophy (BPH) and prevention of prostate cancer. 2. Discussion of Related Art Prostate cancer is a leading cause of death

BACKGROUND OF THE INVENTION 1. Field of the Invention The invention relates to a method and composition for the treatment and alleviation of symptoms of benign prostatic hypertrophy (BPH) and prevention of prostate cancer. 2. Discussion of Related Art Prostate cancer is a leading cause of death

TECHNICAL FIELD This invention generally relates to dietary supplement. It relates specifically to such dietary supplement compositions comprising lycopene and resveratrol exhibiting certain therapeutic effects, including anti-oxidant, anti-arthritis, suppressing carcinoma growth and mitigating

FIELD OF THE INVENTION The present invention relates to a method of reducing the activity of cells, which utilizes pharmaceutical preparations comprising lycopene. The invention further relates to the inhibition of the growth of cancer cells using lycopene as the anticancer active agent. BACKGROUND

STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT Not applicable REFERENCE TO A MICROFICHE APPENDIX Not applicable BACKGROUND OF INVENTION Cancer care is reported to have cost Americans more than $110 billion in 1992, more than 11% of all expenditures spent on diseases in America.